February 17th 2025, 2:00pm
The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.
February 13th 2025, 10:00pm
Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to normal after three months.
February 13th 2025, 9:35pm
Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.
February 13th 2025, 3:10pm
Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower death risk with Talzenna plus Xtandi.
January 16th 2025, 8:00pm
A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance.
January 8th 2025, 2:00pm
A Biologics License Application has been submitted to the FDA for treatment with the kidney cancer imaging PET drug product, Zircaix®.
October 30th 2024, 7:00pm
Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma.
October 14th 2024, 7:00pm
TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.
October 11th 2024, 9:00pm
Removing more lymph nodes during surgery may also increase the risk for death after surgery in muscle-invasive bladder cancer.
October 8th 2024, 5:00pm
Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a helpful tool.
The Importance of Genetic Testing in Metastatic Colorectal Cancer
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
Cancer is Hard Enough Without Infections
How Patients With Cancer Can Avoid Counterfeit Therapeutics Online